Genmab — Januar 2018
-
-
Det er næppe Jeff's nye kursmål alene, der er årsagen til stigningen i dag. Bungy jump elastikken var strukket godt ud. Men lad os håbe at deres begrundelse i opjustering af Darzalex-salget kan være med til at dæmpe den tvivl der opstod ved JnJ q3 og R&D. Nu skal vi bare have nogle ikke alt for dårlige salgstal ved Q4.
-
luk bliver interessant i dag
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind